Pharmacy

AstraZeneca will lay off 94 workers from its campus in the United Kingdom by 2020, according to online publication in-Pharmatechnologist.

Purdue Pharma and the billionaire Sackler family agreed to pay hundreds of millions to resolve the first of more than 1,600 lawsuits accusing the OxyContin maker of fueling the opioid crisis. The landmark deal could lay the groundwork for the resolution…

Louisiana officials will strike a deal with a Gilead Sciences subsidiary to supply hepatitis C medication under a Netflix-style payment model, according to STAT.

San Francisco-based Dignity Health opened its hospital-owned specialty pharmacy March 26.

A first-of-its-kind proposal to create a prescription drug affordability board in Maryland advanced last week after a Maryland House committee overwhelmingly voted in favor of it, according to The Baltimore Sun.

Lawmakers in Texas have proposed two bills that would allow physicians to sell certain medications from their offices in the state, according to a KVEO TV news report.

CVS Health sent letters to 60 drugmakers asking them not to increase the net costs of their drugs in response to a proposed rule that would overhaul the rebate system, according to an Inside Drug Pricing news report.

An HHS official said the agency plans to finalize its proposed rule that would overhaul the rebate system in less than three months, according to Politico's Prescription Pulse newsletter.

OxyContin maker Purdue Pharma and the billionaire Sackler family will pay $270 million to resolve Oklahoma's claims that the company helped fuel the opioid epidemic, according to Reuters.

Thermo Fisher Scientific will buy Brammer Bio for $1.7 billion, making it the latest company jumping into the fast-growing, potentially lucrative field of gene therapy.